CRISPR Therapeutics CRSP announced that it has entered into a collaboration deal with San Diego-based privately held company, ...

The partnership with Sirius expands CRISPR Therapeutics’ modality toolkit, especially in the cardiovascular space.

-Under the agreement, CRISPR Therapeutics will make an upfront payment of $25 million in cash and $70 million in equity to ...

CRISPR Therapeutics and Sirius Therapeutics have formed a strategic ... clinical trials and pipeline products and programs, including, without limitation, expectations regarding data, safety ...

SAN DIEGO & SHANGHAI, May 09, 2025--(BUSINESS WIRE)--Sirius Therapeutics ... clinical programs and expand our pipeline, to deliver "transformative siRNA therapeutics for patients with chronic ...

“We are excited to partner with Sirius, and broaden our ... (i) CRISPR Therapeutics preclinical studies, clinical trials and pipeline products and programs, including, without limitation ...